Hearts & Minds Blog

Esperion Investor Day: Lighting the Way for Phase 2b Results

Tim Mayleben

President and Chief Executive Officer

On July 29th, Esperion held its inaugural investor day in New York City, with a tightly-packed agenda for the half-day… more

“The IPO Age: Onward and Upward” — Insights from the BioCentury TV Roundtable

Tim Mayleben

President and Chief Executive Officer

Recently, I had the pleasure of participating in a roundtable, “The IPO Age: Onward and Upward,” to review how the… more

Posted In: Industry Insights

ACC.14: Spotlighting the Importance of Finding New Therapies for Statin Intolerant Patients

Roger Newton, PhD, FAHA

Executive Chairman and Chief Scientific Officer

Late last month, the American College of Cardiology (ACC) held its 63rd Annual Scientific Session & Expo with more than… more